Athenex Global Harmonization meeting held June 8-10, 2018 in Buffalo, NY (USA)
Our experienced senior management team members have held senior executive roles at multinational pharmaceutical companies and have led the development and regulatory approvals of pharmaceutical products in markets around the globe. Our R&D team members played key roles in the clinical development of numerous significant drugs, including Herceptin, Rituxan, Xeloda, Pegasys, PEG-Intron, Rebetol, IV Temodol, Requip, Suboxone, Subutex and Nothera. The leadership of our commercial team has launched over 50 drugs around the world. A number of our executive officers have significant experience in corporate governance, public capital markets transactions, licensing and partnerships, and mergers and acquisitions. We believe this unique combination of executive skill sets has the potential to create substantial long-term value for investors.